IP Ownership Risk Grows In Booming Cancer Drug Market

By Ryan Hagglund, Lewis Ho and Bonnie Lau ( November 20, 2025, 1:55 PM EST) -- The antibody-drug conjugate, or ADC, space is experiencing an unprecedented surge in dealmaking, establishing itself as one of the most dynamic and high-value domains within biopharma....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login